AI 411: CES edition

Welcome back to a special CES 2026 edition of AI 411, a monthly roundup of AI announcements from across the healthcare industry!

That’s right: We spent the last week in Las Vegas, exploring the 2.6 million square feet of exhibit floor at the Consumer Technology Association’s annual gathering. The trade organization estimated 148,000+ attendees in 2026—the largest CES since the pandemic began.

And as with most tech conferences these days, we couldn’t walk five feet without seeing or hearing something AI related.

In case you weren’t able to attend, here’s a short rundown of some notable AI-powered health tech that stood out to us.

Abbott. On Jan. 5, medical device maker Abbott announced a new feature for its FreeStyle Libre continuous glucose monitoring (CGM) technology called Libre Assist. Libre Assist uses AI to predict how specific food choices will impact glucose and provide recommendations on how to keep glucose levels down. Another major CGM player, Dexcom, also gives users AI-powered advice through its own app.

Eyebot. One exhibit that drew a lot of eyes (get it?) was Eyebot, an AI-assisted machine that provides 90-second eye tests. The General Catalyst-backed startup used the conference to debut its partnership with The Framery at 1-800 Contacts. Want to try it out but couldn’t attend the conference? Walmart and Sam’s Club are piloting the devices in Pennsylvania, per a Dec. 11 Eyebot press release.

.lumen. Romanian startup .lumen showcased its glasses for the blind, a wearable assistive device that helps people with severe visual impairments navigate the world using the same AI technology that guides self-driving cars. The startup also won the 2026 CTA Foundation pitch competition for accessibility. Though they aren’t for sale online yet, the company allows interested buyers to “reserve” the glasses on its website.

Peri. Another exhibit floor standout, Peri, gathers actionable insights on perimenopause symptoms via a small wearable device. Peri is powered by biosensor technology as well as AI-informed analytics, per a Nov. 11 press release from its creator, women’s health company IdentifyHer. It is not yet for sale in the US but is available for pre-order for $449.00.

Transcarent. On Jan. 6, the digital health startup announced the addition of AI agents to its WayFinding platform, a place where employers and employees can get assistance navigating all things health from insurance to scheduling appointments.